Inventor
DEVAL JEROME
US29 patents
⚠️ This page may combine multiple inventors who share the name “DEVAL JEROME”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALIOS BIOPHARMA INC
11 patentsUS9278990B2Mar 8, 2016
Substituted nucleotide analogs
ALIOS BIOPHARMA INC60 citations98
US9073960B2Jul 7, 2015
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC33 citations94
US9862743B2Jan 9, 2018
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC21 citations93
US9365605B2Jun 14, 2016
Cyclic nucleotide analogs
ALIOS BIOPHARMA INC19 citations92
US9815864B2Nov 14, 2017
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC38 citations90
US10370401B2Aug 6, 2019
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC17 citations85
US10464965B2Nov 5, 2019
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC10 citations84
US9441007B2Sep 13, 2016
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC11 citations84
US9346848B2May 24, 2016
Azido nucleosides and nucleotide analogs
ALIOS BIOPHARMA INC17 citations84
US10485815B2Nov 26, 2019
Substituted nucleosides, nucleotides and analogs thereof
ALIOS BIOPHARMA INC5 citations73
US10364226B2Jul 30, 2019
Pyridazinone compounds and uses thereof
ALIOS BIOPHARMA INC3 citations69
ALIGOS THERAPEUTICS INC
11 patentsUS11091467B2Aug 17, 2021
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC6 citations84
US12018015B2Jun 25, 2024
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations71
US12180192B2Dec 31, 2024
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations62
US12534450B2Jan 27, 2026
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC0 citations61
US11760764B2Sep 19, 2023
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations61
US11760761B2Sep 19, 2023
Methods and compositions for targeting PD-L1
ALIGOS THERAPEUTICS INC2 citations61
US11198699B2Dec 14, 2021
Compounds targeting PRMT5
ALIGOS THERAPEUTICS INC1 citations61
US11858913B2Jan 2, 2024
Bicyclic pyridazinones and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11840532B2Dec 12, 2023
Modulators of THR-β and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11793815B2Oct 24, 2023
Oxindoles and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
US11786532B2Oct 17, 2023
2-pyridones and methods of use thereof
ALIGOS THERAPEUTICS INC0 citations52
JANSSEN BIOPHARMA INC
3 patentsUS11149049B2Oct 19, 2021
Substituted nucleosides, nucleotides and analogs thereof
JANSSEN BIOPHARMA INC2 citations73
USRE48171EAug 25, 2020
Substituted nucleosides, nucleotides and analogs thereof
JANSSEN BIOPHARMA INC3 citations73
US11021509B2Jun 1, 2021
Substituted nucleosides, nucleotides and analogs thereof
JANSSEN BIOPHARMA INC1 citations62